Why do not our vaccines reach the high-hanging fruit?
Antigenic diversity of type 1 polioviruses and its implications for efficacy of inactivated polio vaccines
Novel nanoparticle based vaccine against respiratory viruses
Infectious Diseases Conf 2019: Cold chain management at Malawi-Liverpool-Wellcome Trust research pharmacy and at selected vaccination sites: The Phase III Randomized, Double-Blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) among Children Age 9 Months through 12 Years in Blantyre(TyVAC), Malawi study- a case report- John Masiye Ndaferankhande- University of Malawi